Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor × Appointments and Schedules × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Endometrial Neoplasms 2 Solid Tumors 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Colonic Neoplasms 1 Advanced Solid Tumor 1

Interventions

Injections 23 toripalimab 15 pembrolizumab 14 tislelizumab 12 Gemcitabine 8 Cisplatin 7 Carboplatin 7 atezolizumab 6 Paclitaxel 6 spartalizumab 5 Oxaliplatin 5 Leucovorin 5 Irinotecan 5 Fluorouracil 5 Bevacizumab 5 Nivolumab 4 Capecitabine 4 trastuzumab deruxtecan 3 sintilimab 3 olaparib 3 lenvatinib 3 camrelizumab 3 Pemetrexed 3 Drug Therapy 3 Docetaxel 3 Cyclophosphamide 3 Cetuximab 3 Albumin-Bound Paclitaxel 3 penpulimab 2 niraparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06560632 2026-01-16

POLAR

Repare Therapeutics

Phase 1 Terminated

26 enrolled 14 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡